evoke semaglutide trial and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic Alzheimer's disease | Alzheimer's Research & Therapy Weight-loss drug semaglutide does not

Why some doctors combine phentermine and tirzepatide Despite the lack of formal clinical trials, some weight management physicians do prescribe phentermine alongside tirzepatide

Commitment to Branded Medications Klinic offers only FDA-approved branded medications, like Wegovy and Foundayo, which ensure quality, efficacy, and safety

For example, potential effects on alcohol dependency are supported by a recent real-world population propensity-score-matched study of 83,825 patients with obesity, which showed that semaglutide, compared with other non-GLP-1-based obesity medications, was associated with a 50% lower risk for incident and recurrent alcohol use disorders over a 12-month period regardless of T2D status 24

Accessed Apr 29, 2025